Randomised, Placebo-controlled Safety and Pharmacokinetics Study of Novel Rifaximin Formulations in Healthy Volunteers
Clinical trial NCT04529811 · COMPLETED
Trial details
- NCT number
- NCT04529811
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-24
- Primary completion
- 2021-05-09
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.